Real Patients. Measurable Outcomes.
See how MapperHealth's precision medicine platform is delivering better health and lower costs for self-insured employers and the members they serve.
A Midwest Employer Cuts Drug & Medical Spend by 44%
A self-insured employer partnered with RxMapper to bring DNA-guided medication management to their health plan. The results: 91.6% of sequenced members received actionable recommendations, and the program delivered $355,482 in combined drug and medical savings.
44%
Combined cost reduction
91.6%
Received actionable recs
$355K
Total annual savings
An Asymptomatic Patient Discovers 10.8x Alzheimer's Risk — Years Before Symptoms
A 45-year-old male with no symptoms and no family history of Alzheimer's underwent a DxMapper polygenic risk screen. His results revealed a 10.8x elevated odds ratio for late-onset Alzheimer's disease, confirmed by targeted APOE sequencing. What he did with that knowledge changed everything.
10.8×
Odds ratio identified
e4/e4
APOE status confirmed
Asymptomatic
No clinical warning signs
Ready to See What's Possible for Your Plan?
Schedule a demo to walk through how MapperHealth would work for your organization and member population.
Request a Demo